CAPR - Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29 | Benzinga
SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases, will release its financial results for the fourth quarter and full year ended December 31, 2023, after the market close on Thursday, February 29, 2024. Management will then host a webcast and conference call at 4:30 p.m. ET on February 29.
| Title: |
| Capricor Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update Conference Call and Webcast |
| Date: |
| Thursday, February 29, 2024 |
| Time: |
| 4:30 p.m. ET |
| Conference Call Details: |
| Toll-Free: 1-888-886-7786 International: 1-416-764-8658 Conference ID: 83986877 Participants can use guest dial-in numbers above and be answered by an operator or click the Call me™ link for instant telephone access to the event. |